59 related articles for article (PubMed ID: 25821471)
21. Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of
Butz H; Lövey J; Szentkereszty M; Bozsik A; Tóth E; Patócs A
Front Oncol; 2022; 12():849004. PubMed ID: 35419288
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous diagnosis of liver PEComa in a family with known Li-Fraumeni syndrome: a case report.
Galera López MDM; Márquez Rodas I; Agra Pujol C; García Pérez Á; Velasco Sánchez E; Álvarez Álvarez R
Clin Sarcoma Res; 2020 Nov; 10(1):24. PubMed ID: 33292569
[TBL] [Abstract][Full Text] [Related]
23. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
Pan CC; Chung MY; Ng KF; Liu CY; Wang JS; Chai CY; Huang SH; Chen PC; Ho DM
J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
[TBL] [Abstract][Full Text] [Related]
24. Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.
Huľová S; Sycova-Mila Z; Macák D; Janega P; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2018; 31(6):448-452. PubMed ID: 30545225
[TBL] [Abstract][Full Text] [Related]
25. Primary perivascular epithelioid cell tumor of the liver: new case report and literature review.
Ameurtesse H; Chbani L; Bennani A; Toughrai I; Beggui N; Kamaoui I; Elfatemi H; Harmouch T; Amarti A
Diagn Pathol; 2014 Jul; 9():149. PubMed ID: 25034830
[TBL] [Abstract][Full Text] [Related]
26. "Malignant" perivascular epithelioid cell neoplasm: risk stratification and treatment strategies.
Bleeker JS; Quevedo JF; Folpe AL
Sarcoma; 2012; 2012():541626. PubMed ID: 22619565
[TBL] [Abstract][Full Text] [Related]
27. Hepatic perivascular epithelioid cell tumor (PEComa): dynamic CT, MRI, ultrasonography, and pathologic features--analysis of 7 cases and review of the literature.
Tan Y; Xiao EH
Abdom Imaging; 2012 Oct; 37(5):781-7. PubMed ID: 22278345
[TBL] [Abstract][Full Text] [Related]
28. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.
Brimo F; Robinson B; Guo C; Zhou M; Latour M; Epstein JI
Am J Surg Pathol; 2010 May; 34(5):715-22. PubMed ID: 20410812
[TBL] [Abstract][Full Text] [Related]
29. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ; Malinowska-Kolodziej I; Morgan JA; Qin W; Fletcher CD; Vena N; Ligon AH; Antonescu CR; Ramaiya NH; Demetri GD; Kwiatkowski DJ; Maki RG
J Clin Oncol; 2010 Feb; 28(5):835-40. PubMed ID: 20048174
[TBL] [Abstract][Full Text] [Related]
30. Perivascular epithelioid cell tumor.
Armah HB; Parwani AV
Arch Pathol Lab Med; 2009 Apr; 133(4):648-54. PubMed ID: 19391667
[TBL] [Abstract][Full Text] [Related]
31. PEComas: the past, the present and the future.
Martignoni G; Pea M; Reghellin D; Zamboni G; Bonetti F
Virchows Arch; 2008 Feb; 452(2):119-32. PubMed ID: 18080139
[TBL] [Abstract][Full Text] [Related]
32. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.
Folpe AL; Mentzel T; Lehr HA; Fisher C; Balzer BL; Weiss SW
Am J Surg Pathol; 2005 Dec; 29(12):1558-75. PubMed ID: 16327428
[TBL] [Abstract][Full Text] [Related]
33. Germline TP53 mutations and Li-Fraumeni syndrome.
Varley JM
Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
[TBL] [Abstract][Full Text] [Related]
34. Multiple primary cancers in families with Li-Fraumeni syndrome.
Hisada M; Garber JE; Fung CY; Fraumeni JF; Li FP
J Natl Cancer Inst; 1998 Apr; 90(8):606-11. PubMed ID: 9554443
[TBL] [Abstract][Full Text] [Related]
35. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?
Li FP; Fraumeni JF
Ann Intern Med; 1969 Oct; 71(4):747-52. PubMed ID: 5360287
[No Abstract] [Full Text] [Related]
36. PEC and sugar.
Bonetti F; Pea M; Martignoni G; Zamboni G
Am J Surg Pathol; 1992 Mar; 16(3):307-8. PubMed ID: 1599021
[No Abstract] [Full Text] [Related]
37. The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics.
Strong LC; Williams WR; Tainsky MA
Am J Epidemiol; 1992 Jan; 135(2):190-9. PubMed ID: 1536134
[TBL] [Abstract][Full Text] [Related]
38. PEComa in a Young Patient with Known Li-Fraumeni Syndrome.
Neofytou K; Famularo S; Khan AZ
Case Rep Med; 2015; 2015():906981. PubMed ID: 25821471
[TBL] [Abstract][Full Text] [Related]
39. PEComa: what do we know so far?
Hornick JL; Fletcher CD
Histopathology; 2006 Jan; 48(1):75-82. PubMed ID: 16359539
[TBL] [Abstract][Full Text] [Related]
40. PEComa: morphology and genetics of a complex tumor family.
Thway K; Fisher C
Ann Diagn Pathol; 2015 Oct; 19(5):359-68. PubMed ID: 26144278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
